+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

From
From
From
From
From
From
Global Preventive Vaccines Market, 2020-2030 - Product Thumbnail Image

Global Preventive Vaccines Market, 2020-2030

  • Report
  • April 2020
  • 248 Pages
From
From
From
Global Coronavirus Vaccines Pipeline 2020 - Product Thumbnail Image

Global Coronavirus Vaccines Pipeline 2020

  • Report
  • April 2020
  • 200 pages
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
From
Global Bronchodilators Market 2017-2021 - Product Thumbnail Image

Global Bronchodilators Market 2017-2021

  • Report
  • July 2017
  • 83 pages
From
Pertussis (Whooping Cough) - Pipeline Review, H1 2020 - Product Thumbnail Image

Pertussis (Whooping Cough) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 127 pages
From
Loading Indicator
adroll